Patent assignee · EE · COMPANY

IBCC Holding AS

2Patents
2Active
2Granted
38Portfolio score

Filing activity: Jul 4, 2008 → Mar 5, 2010 · 2 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8192744B2 Drug for treating states related to the inhibition of angiogenesis and/or endothelial cell proliferation Physics 5 Active
US8524666B2 Methods of using vimentin to inhibit angiogenesis and endothelial cell proliferation Physics 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.